Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-14-057538

Director sold 8,500 shares at $0.23 ($1,920)

  • Director acquired 8,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kraus Al Director 2014-09-22 Option exercise +8,500 $0.04 $298 1,402,131 D
Kraus Al Director 2014-09-22 Sale −8,500 $0.23 $1,920 1,393,631 D
Derivatives
Kraus Al Director 2014-09-22 Option exercise · Stock Option −8,500 6,210,828 D
Open-market sales · 8,500 sh · avg $0.23 · $1,920
Loading xslF345X03/v389939_4.xml…